Introducing S.C.O.P.E.™: Schizophrenia Clinical Outcome Scenarios and Patient-Provider Engagement—An Interactive Digital Platform to Educate on Schizophrenia Care

Abstract: Introduction: Healthcare professionals (HCPs) face unique challenges when managing patients with schizophrenia. Educational initiatives targeting the most common dilemmas encountered by clinicians, including the frequent problem of partial or nonadherence, may alleviate knowledge gaps and help clarify the role of long-acting injectable antipsychotic agents (LAIs) in treating this population. Methods: A panel of 4 experts in schizophrenia management used empirical evidence to identify 10 key clinical dilemmas where LAIs may be useful. The panel then developed a heuristic, educational tool (S.C.O.P.E.™: Schizophrenia Clinical Outcome Scenarios and Patient-Provider Engagement) based on empirical evidence and expert opinion for clinicians to use when encountering similar scenarios, to help optimize schizophrenia care by prompting consideration of various factors. Results: S.C.O.P.E.™ will be a freely-available resource comprising an interactive digital platform providing educational materials for HCPs involved in the continuum of care for patients with schizophrenia. S.C.O.P.E.™ provides a framework to inform considerations in common clinical scenarios met in inpatient and outpatient settings, as well as questions to consider when patients present to the emergency department. The potential usefulness of LAIs is explored in each scenario. S.C.O.P.E.™ will not replace clinical judgment, guidelines, or continuing medical education, and is not a platform for recording patient-level data, nor intended for payer negotiations or access-related questions by HCPs. Conclusions: S.C.O.P.E.™ will be an educational tool for HCPs to use alongside standard psychiatric evaluations to improve understanding of how to manage common clinical dilemmas when treating patients with schizophrenia and the role of LAIs in schizophrenia management.Short Description: Educational initiatives targeting common dilemmas encountered by clinicians managing patients with schizophrenia may clarify appropriate use of long-acting injectable antipsychotic agents (LAIs) and improve patient outcomes. After identifying 10 key clinical scenarios, a panel of experts developed an interactive digital platform–S.C.O.P.E.™: Schizophrenia Clinical Outcome Scenarios and Patient-Provider Engagement–comprising a framework to inform considerations in inpatient and outpatient settings as well as a set of questions to consider in each scenario.Name of Sponsoring Organization(s): Teva Branded Pharmaceutical Products R&D, Inc.